A pharmacogenetic study of aldehyde oxidase I in patients treated with XK469.

Ramírez J, Kim TW, Liu W, Myers JL, Mirkov S, Owzar K, Watson D, Mulkey F, Gamazon ER, Stock W, Undevia S, Innocenti F, Ratain MJ
Pharmacogenet Genomics. 2014 24 (2): 129-32

PMID: 24300566 · PMCID: PMC3901533 · DOI:10.1097/FPC.0000000000000023

MeSH Terms (13)

Aldehyde Oxidase Antineoplastic Agents Clinical Trials, Phase I as Topic Cohort Studies Genetic Variation Genotype Humans Liver Neoplasms Pharmacogenetics Polymorphism, Single Nucleotide Quantitative Trait Loci Quinoxalines

Connections (1)

This publication is referenced by other Labnodes entities: